Increased expression of IFN-β and ISG enhances the function of natural and adaptive immunity, improves the body’s immune surveillance ability against prostate tumors, and increases the effectiveness of immunotherapy (Yu et al., 2022). This evidence concerns the gene IFNB1 and prostate neoplasm.